MedTrace Logo

Nighttime Dosing of Antihypertensive Drugs in Type 2 Diabetes

NCT01158625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2013-04-04

No results posted yet for this study

Summary

The purpose of this study is to investigate if it is possible to lower the nighttime blood pressure in patients with type 2 diabetes mellitus by shifting the administration of antihypertensive drugs from morning to nighttime.

Conditions

Interventions

OTHER

Change of time of administration

Change of time of administration

Sponsors & Collaborators

  • Regionshospitalet Silkeborg

    collaborator OTHER

  • The Ministry of Science, Technology and Innovation, Denmark

    collaborator OTHER_GOV

  • Central Denmark Region

    collaborator OTHER

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Klavs W Hansen, MD, DrMedSc · Department of Medicine, Regional Hospital Silkeborg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01158625 on ClinicalTrials.gov